nicotinyl alcohol has been researched along with Apolipoprotein B-100, Familial Defective in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonfiglioli, D; Fasoli, A; Sommariva, D; Zanaboni, L | 1 |
| Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 2 |
| Schräpler, P; Schulz, E | 1 |
| Neureuther, G; Schwandt, P; Weisweiler, P | 1 |
| Keller, C; Kormann, BA; Miliczek, KD; Riedel, KG; Wolff-Kormann, PG; Zrenner, E | 1 |
| Keller, C; Wolfram, G; Zoller, W; Zöllner, N | 1 |
| Balabanski, L; Goranov, I; Kerekovska, M; Naumova, R | 1 |
| Demant, T; Hailer, S; Keller, C; Wolfram, G; Zöllner, N | 1 |
1 trial(s) available for nicotinyl alcohol and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
[Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
Topics: Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinyl Alcohol; Pyridines | 1983 |
8 other study(ies) available for nicotinyl alcohol and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
[Effects of nicotinic alcohol therapy on serum lipoproteins in patients with hyperbetalipoproteinemia].
Topics: Adult; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Nicotinyl Alcohol; Pyridines | 1983 |
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Topics: Adolescent; Bezafibrate; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Inositol; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nicotinic Acids; Nicotinyl Alcohol; Xanthinol Niacinate | 1980 |
[Blood levels and effectiveness of beta-pyridyl carbinol in a new controlled release form in subjects with healthy metabolism and in patients with hyperlipoproteinemia II].
Topics: Humans; Hyperlipoproteinemia Type II; Lipids; Nicotinyl Alcohol; Pyridines | 1980 |
The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
Topics: Adult; Aged; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Nicotinyl Alcohol; Phospholipids; Pyridines | 1979 |
[Ocular side effects of beta-pyridylcarbinol].
Topics: Adolescent; Adult; Aged; Color Perception Tests; Color Vision Defects; Female; Fluorescein Angiography; Humans; Hyperlipoproteinemia Type II; Macular Edema; Male; Middle Aged; Nicotinyl Alcohol | 1991 |
Unusual but reversible hepatic lesions following long-term treatment with pyridylcarbinol for familial hypercholesterolemia.
Topics: Adult; Biopsy; Chemical and Drug Induced Liver Injury; Female; Humans; Hyperlipoproteinemia Type II; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Nicotinyl Alcohol; Pyridines; Ultrasonography | 1988 |
[Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
Topics: Bezafibrate; Cholesterol; Drug Evaluation; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Nicotinyl Alcohol; Probucol; Triglycerides | 1987 |
Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.
Topics: Adult; Apolipoproteins; Cholestyramine Resin; Combined Modality Therapy; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Nicotinyl Alcohol; Plasma Exchange | 1985 |